121 related articles for article (PubMed ID: 18594474)
1. Differential long-term effects of carvedilol on proinflammatory and antiinflammatory cytokines, asymmetric dimethylarginine, and left ventricular function in patients with heart failure.
Alfieri AB; Briceno L; Fragasso G; Spoladore R; Palloshi A; Bassanelli G; Montano C; Arioli F; Cuko A; Ruotolo G; Margonato A
J Cardiovasc Pharmacol; 2008 Jul; 52(1):49-54. PubMed ID: 18594474
[TBL] [Abstract][Full Text] [Related]
2. Increased low-grade inflammation is associated with lack of functional response to carvedilol in patients with systolic heart failure.
Fragasso G; Spoladore R; Maranta F; Corti A; Lattuada G; Colombo B; Locatelli M; Salerno A; Calori G; Briceno L; Alfieri AB; Perseghin G; Margonato A
J Cardiovasc Med (Hagerstown); 2013 Jan; 14(1):49-56. PubMed ID: 23018486
[TBL] [Abstract][Full Text] [Related]
3. A controlled study of the effects of carvedilol on clinical events, left ventricular function and proinflammatory cytokines levels in patients with dilated cardiomyopathy.
Tatli E; Kurum T
Can J Cardiol; 2005 Mar; 21(4):344-8. PubMed ID: 15838561
[TBL] [Abstract][Full Text] [Related]
4. Role of beta-adrenergic receptor gene polymorphisms in the long-term effects of beta-blockade with carvedilol in patients with chronic heart failure.
Metra M; Covolo L; Pezzali N; Zacà V; Bugatti S; Lombardi C; Bettari L; Romeo A; Gelatti U; Giubbini R; Donato F; Dei Cas L
Cardiovasc Drugs Ther; 2010 Feb; 24(1):49-60. PubMed ID: 20352314
[TBL] [Abstract][Full Text] [Related]
5. Effects of carvedilol on right ventricular ejection fraction and cytokines levels in patients with systolic heart failure.
Tatli E; Kurum T; Aktoz M; Buyuklu M
Int J Cardiol; 2008 Apr; 125(2):273-6. PubMed ID: 18053592
[TBL] [Abstract][Full Text] [Related]
6. [Effects of carvedilol on functional capacity, left ventricular function, catecholamines and oxidative stress in patients with chronic heart failure].
Castro P; Pérez O; Greig D; Díaz-Araya G; Moraga F; Chiong M; Troncoso R; Padilla I; Vukasovic JL; Corbalán R; Lavandero S
Rev Esp Cardiol; 2004 Nov; 57(11):1053-8. PubMed ID: 15544754
[TBL] [Abstract][Full Text] [Related]
7. Effects of carvedilol on left ventricular diastolic function and chamber volumes in advanced heart failure.
Palazzuoli A; Quatrini I; Vecchiato L; Scali C; De Paola V; Iovine F; Martini G; Nuti R
Minerva Cardioangiol; 2005 Aug; 53(4):321-8. PubMed ID: 16177676
[TBL] [Abstract][Full Text] [Related]
8. Effects of nebivolol versus carvedilol on left ventricular function in patients with chronic heart failure and reduced left ventricular systolic function.
Lombardo RM; Reina C; Abrignani MG; Rizzo PA; Braschi A; De Castro S
Am J Cardiovasc Drugs; 2006; 6(4):259-63. PubMed ID: 16913827
[TBL] [Abstract][Full Text] [Related]
9. Carvedilol therapy is associated with a sustained decline in brain natriuretic peptide levels in patients with congestive heart failure.
Frantz RP; Olson LJ; Grill D; Moualla SK; Nelson SM; Nobrega TP; Hanna RD; Backes RJ; Mookadam F; Heublein D; Bailey KR; Burnett JC
Am Heart J; 2005 Mar; 149(3):541-7. PubMed ID: 15864245
[TBL] [Abstract][Full Text] [Related]
10. Discharge use of carvedilol is associated with higher survival in Japanese elderly patients with heart failure regardless of left ventricular ejection fraction.
Yanagihara K; Kinugasa Y; Sugihara S; Hirai M; Yamada K; Ishida K; Kato M; Yamamoto K
J Cardiovasc Pharmacol; 2013 Nov; 62(5):485-90. PubMed ID: 24072178
[TBL] [Abstract][Full Text] [Related]
11. Prospective crossover comparison of carvedilol and metoprolol in patients with chronic heart failure.
Maack C; Elter T; Nickenig G; LaRosee K; Crivaro M; Stäblein A; Wuttke H; Böhm M
J Am Coll Cardiol; 2001 Oct; 38(4):939-46. PubMed ID: 11583862
[TBL] [Abstract][Full Text] [Related]
12. Effect of Carvedilol on Serum Heart-type Fatty Acid-binding Protein, Brain Natriuretic Peptide, and Cardiac Function in Patients With Chronic Heart Failure.
Sun YP; Wei CP; Ma SC; Zhang YF; Qiao LY; Li DH; Shan RB
J Cardiovasc Pharmacol; 2015 May; 65(5):480-4. PubMed ID: 25945865
[TBL] [Abstract][Full Text] [Related]
13. [A failed improvement in pulmonary function and exercise capacity with carvedilol in congestive heart failure despite an excellent effect on left ventricular function].
Guazzi M; Pontone G; Trevisi N; Lomanto M; Matturri M; Agostoni P
Cardiologia; 1998 Feb; 43(2):181-7. PubMed ID: 9557374
[TBL] [Abstract][Full Text] [Related]
14. Effects of carvedilol on plasma levels of pro-inflammatory cytokines in patients with ischemic and nonischemic dilated cardiomyopathy.
Kurum T; Tatli E; Yuksel M
Tex Heart Inst J; 2007; 34(1):52-9. PubMed ID: 17420794
[TBL] [Abstract][Full Text] [Related]
15. Carvedilol and nebivolol improve left ventricular systolic functions in patients with non-ischemic heart failure.
Karabacak M; Doğan A; Tayyar Ş; Özaydın M; Erdoğan D
Anatol J Cardiol; 2015 Apr; 15(4):271-6. PubMed ID: 25413223
[TBL] [Abstract][Full Text] [Related]
16. Impact of initiating carvedilol before angiotensin-converting enzyme inhibitor therapy on cardiac function in newly diagnosed heart failure.
Sliwa K; Norton GR; Kone N; Candy G; Kachope J; Woodiwiss AJ; Libhaber C; Sareli P; Essop R
J Am Coll Cardiol; 2004 Nov; 44(9):1825-30. PubMed ID: 15519014
[TBL] [Abstract][Full Text] [Related]
17. Comparison of outcomes and usefulness of carvedilol across a spectrum of left ventricular ejection fractions in patients with heart failure in clinical practice.
Massie BM; Nelson JJ; Lukas MA; Greenberg B; Fowler MB; Gilbert EM; Abraham WT; Lottes SR; Franciosa JA;
Am J Cardiol; 2007 May; 99(9):1263-8. PubMed ID: 17478155
[TBL] [Abstract][Full Text] [Related]
18. Tolerability and efficacy of carvedilol in patients with New York Heart Association class IV heart failure.
Macdonald PS; Keogh AM; Aboyoun CL; Lund M; Amor R; McCaffrey DJ
J Am Coll Cardiol; 1999 Mar; 33(4):924-31. PubMed ID: 10091817
[TBL] [Abstract][Full Text] [Related]
19. Concentration of BNP, endothelin 1, pro-inflammatory cytokines (TNF-alpha, IL-6) and exercise capacity in patients with heart failure treated with carvedilol.
Nessler J; Nessler B; Kitliński M; Gackowski A; Piwowarska W; Stepniewski M
Kardiol Pol; 2008 Feb; 66(2):144-51; discussion 152-3. PubMed ID: 18344152
[TBL] [Abstract][Full Text] [Related]
20. Randomised, placebo-controlled trial of carvedilol in patients with congestive heart failure due to ischaemic heart disease. Australia/New Zealand Heart Failure Research Collaborative Group.
Lancet; 1997 Feb; 349(9049):375-80. PubMed ID: 9033462
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
